Award
NIH Reporter #1R15HL181657-01A1
RESPOND: Repurposing Drugs for Respiratory Disorders Using a Hybrid Neuro-Symbolic AI Approach
Recipient
Not specified
Award Amount
$562,500.00
Ceiling
$562,500.00
Awarded
July 10, 2026
Identifier
1R15HL181657-01A1
Award for a project to repurpose FDA-approved drugs for respiratory disorders using AI, funded by NHLBI with $562,500 from 2026 to 2029.
Description
This project aims to improve public health by repurposing FDA-approved drugs for pulmonary arterial hypertension (PAH) and idiopathic pulmonary fibrosis (IPF). It involves AI-driven drug discovery, laboratory testing, and research training for students. The project is funded by NHLBI under grant PAR-25-134, with a total award amount of $562,500, spanning from July 15, 2026, to June 30, 2029.